SELP/SELE genetic region and an additional two SNPs, rs3917768 and rs4987361, were associated with sl-selectin levels in African Americans. These variants accounted for a portion of protein variance that ranged from 4 % in Hispanic to 14 % in African Americans. To investigate the relationship of these variants with CVD, 6,317 subjects were used. No significant association was found between any of the identified SNPs and carotid intima-media thickness or presence of carotid plaque using linear and logistic regression, respectively. Similarly no significant results were found for coronary artery calcium or coronary heart disease events. In conclusion, we found that variants within the SELL gene are associated with sl-selectin levels. Despite accounting for a significant portion of the protein level variance, none of the variants was associated with clinical or subclinical CVD.
Introduction
Cardiovascular disease (CVD) is the main cause of morbidity and mortality in the United States (Go et al. 2014) . Inflammation plays a pivotal role in atherosclerosis; in particular, the adhesion of leukocyte to endothelial cells represents an early step of plaque formation (Libby 2002; Ross 1999; Williams and Tabas 2002) . l-Selectin is constitutively expressed on leukocytes and has an essential role on the initial steps of their adhesion to the endothelium during inflammation (Wedepohl et al. 2012) . Given its activity during early recruitment of leukocytes at inflammatory foci, previous in vivo studies suggested a potential role of l-selectin in the development and progression of subclinical atherosclerosis (Eriksson et al. 2001; Galkina et al. 2006) . l-Selectin is enzymatically cleaved from the leukocyte surface (Humbria et al. 1994) .
Endoproteolytic cleavage regulates both homeostatic and activation-induced changes in cell surface l-selectin density during inflammation. In particular, blocking l-selectin shedding resulted in enhanced cell-bound l-selectin expression and increase neutrophils migration to inflamed areas (Venturi et al. 2003) . On the contrary, there is some evidence that soluble l-selectin can competitively block other selectins' receptors reducing leukocyteendothelium interactions. Relatively high levels of soluble l-selectin (sl-selectin) were observed in the general population, suggesting a possible role of the shedding process in the physiologic surface-bound protein turnover (Ponthieux et al. 2004 ). In addition, previous studies observed a long half-life for sl-selectin in animal models, suggesting that levels may remain elevated for many hours after the protein has been shed (Tu et al. 2002) .
Only a few case-control studies have assessed the association of sl-selectin with CVD, with results being inconsistent. Within the Multi-Ethnic Study of Atherosclerosis (MESA) cohort, we found no association between plasma or serum sl-selectin levels and subclinical or clinical CVD (Berardi et al. 2014) . However, genetic variants associated with the protein levels may be a better surrogate of levels of sl-selectin over time, and exploring the association of these variants with clinical and subclinical CVD could shed light on the importance of this protein in the pathogenesis of CVD. This approach was previously used for P-selectin; in particular, multiple variants of the SELP gene were shown to be associated with circulating P-selectin levels in community-based samples (Lee et al. 2008; Reiner et al. 2008) . Similarly, several variants of the ICAM1 gene have been associated with soluble ICAM-1 levels (Bielinski et al. 2008 (Bielinski et al. , 2011 .
Little is currently known about the genetic determinants of sl-selectin levels, with previous association studies limited to two relatively small studies evaluating candidate single nucleotide polymorphisms (SNP) in the local region of the l-selectin protein coding gene (SELL). Wei et al. identified a significant association with SELL missense SNP rs2229569 (C > T; p.P226S) in a Chinese population, determining the SNP to also be associated with ischemic stroke (Wei et al. 2011 ). Russell et al. identified significant associations with SELL missense variant rs1131498 (previously denoted rs3177980; T > C, p.F206L) and 3′ untranslated region (UTR) SNP rs12938 (T > C) in a study of systemic lupus erythematosus (Russell et al. 2005 ). Hajilooi et al. additionally identified rs1131498 to be associated with coronary heart disease (CHD) in an Iranian population (Hajilooi et al. 2006) . We sought to identify potential genetic surrogates of circulating sl-selectin levels in a large multi-ethnic population using comprehensive genetic data heavily enriched for protein coding variation. We investigated the importance of genetic variants in determining the levels of circulating sl-selectin and the association of these variants with clinical and subclinical CVD.
Materials and methods

Multi-Ethnic Study of Atherosclerosis population
The Multi-Ethnic Study of Atherosclerosis (MESA) is a multi-center population-based prospective cohort study initiated in July 2000 to investigate subclinical cardiovascular endpoints in 6,814 African, non-Hispanic white, Chinese, and Hispanic American men and women. MESA participants were examined at one of six field centers located in Baltimore, MD; Chicago, IL; Forsyth County, NC; Los Angeles County, CA; Northern Manhattan, NY; and Saint Paul, MN. Detailed methods have been described elsewhere (Bild et al. 2002) .
At each visit, information on demographics, cardiovascular risk factors, past medical history and co-morbidities, social history, family history, and medications was collected through a combination of self-administered questionnaires and interview-administered questionnaires. Height was measured while participants were standing without shoes, heels together against a vertical mounted ruler. BMI was calculated as weight (kg)/height 2 (m 2 ). Resting seated blood pressure was measured three times using an automated oscillometric method (Dinamap), and the average of the second and third readings is used in analyses. Hypertension was defined according to the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) guidelines as systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg, or use of anti-hypertensive medications (Chobanian et al. 2003) . Diabetes was defined as any participant who self-reported a physician diagnosis, used diabetic medication, had a fasting glucose ≥126 mg/dL, or a non-fasting glucose of ≥200 mg/dL. Serum glucose was assayed by a hexokinase/ glucose-6-phosphate dehydrogenase method. Triglycerides were measured in plasma by a glycerol blanked enzymatic method, and cholesterol was measured in plasma using a cholesterol oxidase method. HDL cholesterol was measured by the cholesterol oxidase method after precipitation of non-HDL cholesterol with magnesium/dextran. LDL cholesterol was calculated in specimens having a triglyceride <400 mg/dL via the Friedewald equation.
Genetic association analysis sample
To identify genetic variants associated with circulating sl-selectin levels, a race/ethnicity stratified random sample of 2,880 individuals was used. At Exam 2, the first follow-up visit after enrollment (2002) (2003) (2004) , serum samples were available for 2,441 participants in the random sample. Of those, 38 individuals were excluded; 34 due to the occurrence of CVD prior to Exam 2, 1 due to cognitive impairment, and 3 due to inconsistencies between their self-reported race/ethnicity and the ethnic group that was actively enrolled by the field center. sl-selectin and DNA samples for the genetic analysis were, therefore, available in 2,403 participants, about 600 of each race/ethnicity.
Blood samples were obtained from fasting participants as previously described (Bild et al. 2002) . Serum was obtained allowing blood samples to clot at room temperature for 40 min. Samples were centrifuged at 4 °C at 2,000g × 15 min or 3,000g × 10 min for a total of 30,000g-min, serum was aliquoted and stored frozen at −70 °C. A single aliquot was thawed at room temperature and circulating sl-selectin was measured immediately by a quantitative sandwich enzyme-linked immunosorbent assay (ELISA) using the Human l-selectin/CD62L Immunoassay kit (R&D Systems, Minneapolis, MN). The inter-assay coefficient of variation of the MESA laboratory was 6.7 % at a mean concentration of 943 ng/mL for an in-house serum pooled control and 7.9 % at a mean concentration of 866 ng/mL for a lyophilized control. The manufacturer's minimum detection level is 0.3 ng/mL.
Sample to test the association of SNPs with cardiovascular outcomes
The subset of the Exam 1 (2000) (2001) (2002) population that gave informed consent for DNA studies (n = 6,317; 1,634 African, 764 Chinese, 2,491 non-Hispanic white and 1,428 Hispanic Americans) was used to test the association of identified variants with clinical and subclinical CVD. Subclinical endpoints of interest were common carotid intima-media thickness (IMT) and presence of carotid plaque measured via ultrasound, and coronary artery calcium (CAC) measured via computed tomography. Standard protocols were used in each field center as previously described (Carr et al. 2005; Polak et al. 2013 ). In addition, incidence of CHD, defined as myocardial infarction (MI), resuscitated cardiac arrest, angina, and CHD death. Event ascertainment methods are detailed elsewhere (Folsom et al. 2008) . In brief, public files (death certificates), medical records from hospitalizations, autopsy reports, and phone interviews from participants at 9-12 month intervals, and in some instances, interviews or questionnaires from their physicians, relatives, or friends were used. Information was reviewed by two independent reviewers for adjudication of an event.
Genetic data
The genetic data consist of four genotype panels: Exome chip, (Huyghe et al. 2013 ) Cardio-Metabochip (Voight et al. 2012 ), i-Select.HG18 (IBC) (Keating et al. 2008) , and MESA Candidate Gene (Illumina Golden Gate assay). The MESA Candidate Gene panel was run on a random sample of 720 participants from each race/ethnic group. All other SNP panels were genotyped using all MESA participants who consented for genetic studies (n = 6,323). Overall 417,752 SNPs in African Americans; 418,460 SNPs in Chinese; 417,771 SNPs in non-Hispanic whites; and 417,770 SNPs in Hispanics passed quality control procedures. All four panels had quality control performed on their genotype data prior to the merge. The data were merged in several steps using PLINK v1.07 (Purcell et al. 2007 ).
Statistical analysis
Participant characteristics were summarized using mean, standard deviation, and select percentiles for continuous variables, and number and percent for categorical variables within each race/ethnicity. These were compared across races/ethnicities using analysis of variance (Kruskal-Wallis) for continuous variables and the Chi square test (exact) for categorical variables. For this study, a two-stage analysis approach was applied. First, the association of sl-selectin values with genome-wide genetic variants was assessed using linear regression under an additive genetic model using PLINK v1.07. Population stratification was assessed using STRUCTURE and using EigenStrat for participants with genome-wide SNP data (Patterson et al. 2006) . Appropriate principal components (PCs) were included as covariates to adjust for population stratification.
Following the genome-wide approach, we identified one genetic variant that was significant across all four races/ ethnicities. To assess potential additional independent associations in the region of the originally identified SNP, we applied race/ethnicity-specific elastic net models using the glmnet package in R (Friedman et al. 2010) . The elastic net is a penalized regression approach that combines LASSO and ridge regression to simultaneously perform parameter shrinkage and variable selection. For our models, the mixing parameter α was set equal to 0.95 to accommodate linkage disequilibrium (LD), while the penalty parameter λ was selected based upon tenfold cross-validation of the mean-squared prediction error. Age, sex, and the originally identified SNP were included as unpenalized covariates, with the previously used PCs capturing population stratification excluded from this and all further regression analyses due to the poor correlation between global and local ancestry (Qin et al. 2010 ). SNPs were modeled under an additive genetic model and missing genotypes imputed with mean observed values. Imputation was necessary for the penalized regression; however, the overall number of imputed SNPs was minimal as we used a SNP call rate threshold of at least 90 %.
The association of genetic variants identified in the twostage analysis with subclinical outcomes was assessed using linear regression for IMT, logistic regression for the presence of carotid plaque, and the Tobit model (Fornage et al. 2004 ) for CAC score. The Tobit model accounts for the large percentage of zero measurements found in the CAC distribution. The association of genetic variants with time-to-CHD was assessed using Cox proportional hazard models. All regression models were stratified by race/ ethnicity.
Results
For the first step of the analysis, the subset of the MESA population including 2,403 individuals was used (Supplemental Figure S1 ); sample characteristics are presented Table S1 . Genetic variants significantly (p < 10 −5
) associated with sl-selectin levels for each race/ ethnicity after adjustment for age, sex, and principal components are listed in Supplemental Table S2 . The majority of significantly associated SNPs are located in the genes encoding for l-selectin (SELL), P-selectin (SELP), and E-selectin (SELE). One common SNP in SELL, rs12938, was significantly associated in all four races/ethnicities (Fig. 1) .
To evaluate potential additional associations, in the second step of the analysis, variants located in the SELL/ SELP/SELE region were assessed using elastic net models in each race/ethnicity. SNP rs12938 was the only variant that remained in the model for Chinese, non-Hispanic white, and Hispanic Americans. For African Americans, rs12938, rs3917768, and rs4987361 remained in the model (Table 1; Fig. 2 ). The C allele of SNP rs12938 was associated with significantly lower sl-selectin levels and the SNP explained an additional 6, 12 and 4 % of the total protein variance after adjusting for age and sex in Chinese, nonHispanic white, and Hispanic Americans, respectively. Among African Americans, the three SNPs associated with sl-selectin levels accounted for an additional 14 % of the total protein variance after adjusting for age and sex.
The association of these genetic variants with clinical and subclinical CVD was assessed among Exam 1 participants who gave informed consent for genotype analysis (93 %). Table 2 summarizes the population characteristics, as well as the prevalence of subclinical disease and incident events over a median follow-up of 10.1 years. As previously described, within this population, significant differences in the prevalence of traditional cardiovascular risk factors across races/ethnicities were observed. In addition, subclinical CVD was more prevalent among non-Hispanic whites. Within the Exam 1 population, no association was found between SNPs associated with sl-selectin and clinical or subclinical CVD. In non-Hispanic white, Chinese, and Hispanic Americans, none of the investigated outcomes was associated with the SNP rs12938, after adjustment of the significance threshold using the Bonferroni method (accounting for four outcomes: 0.05/4 = 0.0125), as shown in Table 3 . Similar results were found for rs12938, rs3917768 and rs4987361 within African Americans (Table 4) .
Discussion
In this large, multi-ethnic population, we found that variants of the SELL gene are significantly associated with circulating levels of sl-selectin. In particular, we found that the C allele of SNP rs12938 is associated with lower levels of sl-selectin in all races/ethnicities. In African Americans, two additional SNPs, rs4987361 and rs3917768, were identified using a penalized regression approach on the SELL/ SELP/SELE region. Again, these variants are associated with lower levels of the circulating protein. However, none of these SNPs that account for a significant portion of the variance of sl-selectin levels was associated with subclinical or clinical atherosclerosis. Table 1 Genetic variants on SELL/SELP/SELE associated with soluble l-selectin (sl-selectin) using elastic net models
The minor allele for each SNP is rs12938 (T), rs3917768 (C), and rs4987361 (C) based on RefSNP
The mean standard deviation (SD) for sl-selectin was 864 (194), 833 (175), 955 (215), and 903 (190) for African, Chinese, Non-Hispanic white, and Hispanic Americans, respectively MAF minor allele frequency, SD standard deviation, SNPs single nucleotide polymorphisms a A = adenine, G = guanine, C = cytosine, and T = thymine b p value derived from linear regression assuming additivity, adjusting for age and sex (74) 50-149, n (%) 275 (11) 105 (14) 160 (10) 153 (11) 150-399, n (%) 308 (12) 70 (9) 118 (7) 105 (7) >400, n (%) 327 (13) 51 (7) 130 (8) 116 (8) IMT, mm 0.7 (0.2) 0.7 (0.2) 0.7 (0.2) 0.7 (0.2) <0.0001
Carotid plaque, n (%) Yes 1,139 (47) 203 (27) 701 (44) 554 (40) <0.0001 CHD events (all), n (%) thru 2012 188 (8) 34 (5) 100 (6) 91 (6) 
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The SELL missense SNP rs1131498, previously reported to be associated with sl-selectin (Russell et al. 2005 ) was replicated in two of our racial subcohorts (Hispanic and non-Hispanic white Americans) but was not significant in the remaining two (African and Chinese Americans). Additionally, as Fig. 1 demonstrates, there is strong LD (r 2 > 0.6) present between rs1131498 and rs12938 in the same two subcohorts that have significant rs1131498 association findings, yet modest LD (r 2 < 0.2) for the two that do not. The context of these findings suggests that rs12938 may be the underlying causal variant, and that rs1131498 is tagging rs12938 in populations where LD is present between the two SNPs.
SNP rs12938 is located in the 3′ untranslated region (UTR) of the SELL gene on Chromosome 1 and has been associated with sl-selectin levels in one previous study that included 278 lupus cases and 230 control siblings of European descent (Russell et al. 2005) . In that study, three SNPs were identified as potentially relevant in determining sl-selectin levels; in particular, rs1131498 was suggested to be the putative causative SNP. Although Russell et al. surmised that an independent effect of rs12938 on sl-selectin may be driven by post-transcriptional regulation, they limited their analysis to in silico prediction of the rs12938 alternate allele on mRNA stability (Conne et al. 2000; Russell et al. 2005) , concluding that there was little evidence of such a mechanism in place and that SNP's effect was likely modest relative to the missense variant rs1131498. However, an alternative proposition for the functional relevance of rs12938 would be RNA silencing through modification of micro-RNA (miRNA)-binding sites. We queried PolymiRTS v3.0 (Bhattacharya et al. 2014) , an online database for SNP effects on RNA silencing-based post-transcriptional regulation, to evaluate the predicted impact of rs12938 on miRNA-binding motifs. This analysis returned two putative miRNA-binding sites created by the rs12938 C allele (Table 5) , potentially inducing post-transcriptional downregulation of SELL mRNA. Consistent with our results, previous expression quantitative trait loci (eQTL) studies reported rs12938 to be associated with SELL expression (Battle et al. 2014; Lappalainen et al. 2013; Xia et al. 2012) . These previous eQTL association findings implicate this variant in the regulation of l-selectin mRNA levels, which in turn may correlate with protein expression on the leukocyte surface. The two additional SNPs identified in African Americans represent novel findings and have not been previously associated with sl-selectin levels. Additionally, rs2229569, reported by Wei et al. (2011) , was not significantly associated for any race/ethnicity (p > 0.05 for all analyses). SELL SNPs explained a significant portion of the variance of sl-selectin; however, there was no evidence of an association with subclinical atherosclerosis or CVD outcomes. These results are inconsistent with a previous study conducted within the Iranian population that found an association between the SNP rs1131498 on the SELL gene and CHD (Hajilooi et al. 2006) . In fact, this SNP is in linkage disequilibrium with rs12938 among nonHispanic whites in our study (r 2 = 0.69). Several reasons could explain our results. First, the variance explained by the SNPs we identified ranged from 4 to 14 % in the four race/ethnic groups. While statistically significant, the variation explained by SELL variants may be an insufficient surrogate of protein levels. Second, our ability to identify additional variants accounting for sl-selectin levels may be hindered by the inability of the circulating portion of sl-selectin to accurately reflect the cell-bound protein expression. There is some evidence suggesting that circulating l-selectin has a long half-life, and consequently does not correlate with the cell expression of the protein (Tu et al. 2002) . Third, it is possible that, while the SNPs that we identified have some influence on the protein levels, other factors, genetic or not, may be more important and thus more closely related to the outcome. For example, there may be non-synonymous SNPs that affect the protein structure and ultimately the function of l-selectin, but do not influence protein levels. Therefore, any SNPs that affect those characteristics may not be identified by looking for associations with circulating levels. Finally, these results could suggest a limited involvement of l-selectin in atherosclerosis. Other components of the selectin family may be more important in the initiation and progression on atherosclerosis compared to l-selectin.
Limitations and strengths
Some limitations need to be acknowledged. In this study, we did not measure the cellular expression of l-selectin, as only frozen serum samples were available and these were not suitable for flow cytometry. In addition, while comprehensive genetic data have been used in our analysis, rare variants may not be captured. Finally, as the MESA population is relatively young, the number of CVD events observed was lower than in other studies, which may have hindered our ability to fully explore the association between SELL genetic variants and clinical CVD. The main strength of our study is the large, multi-ethnic sample, coupled with the availability of comprehensive genetic data enriched for protein coding variation. Importantly, we demonstrate the utility of trans-ethnic analyses to provide additional insight into likely causal variants. Furthermore, MESA includes a large population with a reasonably long follow-up time for ascertainment of CVD events.
Conclusion
In conclusion, we identified variants in SELL accounting for a significant portion of the variance of circulating sl-selectin. Using trans-ethnic analyses, we show that rs12938, a variant previously associated with the quantitative regulation of mRNA and protein expression, was associated with sl-selectin in all four race/ethnic groups. Despite accounting for significant variance of protein level, this SNP, or other SNPs associated with the soluble protein levels, were not significantly related to clinical or subclinical CVD.
Acknowledgments The authors thank the other investigators, the staff, and the participants of the MESA study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org. MESA is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support is provided by grants and contracts N01 HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169 and RR-024156. Funding for adhesion protein levels was provided by NHLBI by grant R01HL98077. NIH/NIEHS P50 ES015915 "The Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air) is supported by the U.S. Environmental Protection Agency (EPA) under Science to Achieve Results (STAR) Program Grant # RD831697 and NIH/NIEHS P50 ES015915 award. Although the research described in this presentation has been funded wholly or in part by the United States Environmental Protection Agency through RD831697 to the University of Washington, it has not been subjected to the Agency's required peer and policy review and, therefore, does not necessarily reflect the views of the Agency and no official endorsement should be inferred." "The provision of genotyping data was supported in part by the National Center for Advancing Translational Sciences, CTSI grant UL1TR000124, and the National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) grant DK063491 to the Southern California Diabetes Endocrinology Research Center". 
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical standard
The institutional review boards at each of the six field centers approved the study. Informed consent was obtained from all study subjects.
